Ingmar Bruns - Insider Trading & Ownership

Location
C/O Trillium Therapeutics Inc., 2488 Dunwin Drive, Mississauga, Ontario, Canada
Summary
The estimated net worth of Ingmar Bruns is at least $83.6K dollars as of February 12, 2025. Ingmar Bruns is the Chief Medical Officer of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $83.6K.
Signature
/s/ Andrea Paul, attorney-in-fact for Ingmar Bruns
All Insider Reports
All Insider Reports

Ownership of Ingmar Bruns

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ZNTL Zentalis Pharmaceuticals, Inc. Chief Medical Officer $83.6K +$45.7K +120% Feb 6, 2025
TRIL Trillium Therapeutics Inc. Chief Medical Officer Nov 17, 2021

Insider Transactions Reported by Ingmar Bruns:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.